Luyan Pharma Co Ltd
Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian… Read more
Luyan Pharma Co Ltd (002788) - Total Liabilities
Latest total liabilities as of September 2025: CN¥9.78 Billion CNY
Based on the latest financial reports, Luyan Pharma Co Ltd (002788) has total liabilities worth CN¥9.78 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Luyan Pharma Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Luyan Pharma Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Luyan Pharma Co Ltd Competitors by Total Liabilities
The table below lists competitors of Luyan Pharma Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Investis Holding SA
SW:IREN
|
Switzerland | CHF839.14 Million |
|
Teyi Pharmaceutical Group Co Ltd
SHE:002728
|
China | CN¥417.67 Million |
|
Chongqing Shunbo Aluminum Co Ltd
SHE:002996
|
China | CN¥11.89 Billion |
|
The Hongkong and Shanghai Hotels Limited
F:HSG
|
Germany | €20.39 Billion |
|
Vishay Precision Group Inc
NYSE:VPG
|
USA | $124.52 Million |
|
Internacional de Cerámica S.A.B. de C.V
MX:CERAMICB
|
Mexico | MX$15.32 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Luyan Pharma Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Luyan Pharma Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Luyan Pharma Co Ltd (2011–2024)
The table below shows the annual total liabilities of Luyan Pharma Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥9.45 Billion | +7.15% |
| 2023-12-31 | CN¥8.82 Billion | -1.96% |
| 2022-12-31 | CN¥8.99 Billion | +21.00% |
| 2021-12-31 | CN¥7.43 Billion | +23.29% |
| 2020-12-31 | CN¥6.03 Billion | +6.70% |
| 2019-12-31 | CN¥5.65 Billion | +27.92% |
| 2018-12-31 | CN¥4.42 Billion | +23.86% |
| 2017-12-31 | CN¥3.57 Billion | +67.16% |
| 2016-12-31 | CN¥2.13 Billion | -20.49% |
| 2015-12-31 | CN¥2.68 Billion | +0.69% |
| 2014-12-31 | CN¥2.66 Billion | +17.50% |
| 2013-12-31 | CN¥2.27 Billion | +27.67% |
| 2012-12-31 | CN¥1.78 Billion | +82.53% |
| 2011-12-31 | CN¥973.17 Million | -- |